Abstract
Background
Inappropriate prescribing is a known risk factor for adverse drug event occurrence in the elderly. In various countries, several studies have used insurance healthcare databases to estimate the national prevalence of potentially inappropriate medications (PIM) in the elderly, as defined by explicit PIM lists. Recently, a representative sample of the French National Insurance Healthcare database, known as the “Echantillon Généraliste des Bénéficiaires” (EGB), was created, making it possible to assess the quality of drug prescription in France. Our objective was to evaluate the prevalence and the regional distribution of PIM prescription in the elderly aged 75 years and over in France, using the French PIM list and the EGB database.
Methods
The list of drugs reimbursed to patients aged 75 years and over from 1 March 2007 to 29 February 2008 was extracted from the EGB. Drugs were classified as inappropriate using the French PIM list. A PIM user was defined as a person receiving at least one PIM reimbursement during the study period. Interregion variability was estimated from logistic regression.
Results
In 53.6% (95% CI: 53.0–54.1) of the elderly aged 75 years and over, at least one PIM was given during the study period. The three main drug groups identified were cerebral vasodilators (19.4%), drugs with antimuscarinic properties (19.3%), and long half-life benzodiazepines (17.8%). There was an important disparity in PIM prescription among the French regions. In 14 out of 22 regions, the risk of PIM prescription was significantly elevated. This geographical variation differed for the different drug groups.
Conclusion
PIM prescription in the elderly is a major and worrying problem in France. As in other countries, recent accessibility of the National Insurance Healthcare database makes it possible to create local indicators that the regional health agencies could use to manage public health policy in closer alignment to the needs of the patients within each French region.
Similar content being viewed by others
References
Merle L, Laroche ML, Dantoine T, Charmes JP (2005) Predicting and preventing adverse drug reactions in the very old. Drugs Aging 22(5):375–392
Ministère de la Santé (2004) Loi n°2004–806 du 09 août 2004, relative à la politique de santé publique. Journal Officiel
Beers MH (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 157(14):1531–1536
Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC (1991) Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 151(9):1825–1832
Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH (2003) Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163(22):2716–2724. doi:10.1001/archinte.163.22.2716163/22/2716
Laroche ML, Charmes JP, Bouthier F, Merle L (2009) Inappropriate medications in the elderly. Clin Pharmacol Ther 85(1):94–97. doi:10.1038/clpt2008.214
Laroche ML, Charmes JP, Merle L (2007) Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 63(8):725–731. doi:10.1007/s00228-007-0324-2
McLeod PJ, Huang AR, Tamblyn RM, Gayton DC (1997) Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 156(3):385–391
Barry PJ, O'Keefe N, O'Connor KA, O'Mahony D (2006) Inappropriate prescribing in the elderly: a comparison of the Beers criteria and the improved prescribing in the elderly tool (IPET) in acutely ill elderly hospitalized patients. J Clin Pharm Ther 31(6):617–626. doi:10.1111/j.1365-2710.2006.00783.x
Bongue B, Naudin F, Laroche ML, Galteau MM, Guy C, Gueguen R, Convers JP, Colvez A, Maarouf N (2009) Trends of the potentially inappropriate medication consumption over 10 years in older adults in the East of France. Pharmacoepidemiol Drug Saf 18(12):1125–1133. doi:10.1002/pds.1762
Fialova D, Topinkova E, Gambassi G, Finne-Soveri H, Jonsson PV, Carpenter I, Schroll M, Onder G, Sorbye LW, Wagner C, Reissigova J, Bernabei R (2005) Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 293(11):1348–1358. doi:10.1001/jama.293.11.1348293/11/1348
Laroche ML, Charmes JP, Nouaille Y, Fourrier A, Merle L (2006) Impact of hospitalisation in an acute medical geriatric unit on potentially inappropriate medication use. Drugs Aging 23(1):49–59
Aparasu RR, Mort JR (2000) Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother 34(3):338–346
Cannon KT, Choi MM, Zuniga MA (2006) Potentially inappropriate medication use in elderly patients receiving home health care: a retrospective data analysis. Am J Geriatr Pharmacother 4(2):134–143. doi:10.1016/j.amjopharm.2006.06.010
Viswanathan H, Bharmal M, Thomas J 3rd (2005) Prevalence and correlates of potentially inappropriate prescribing among ambulatory older patients in the year 2001: comparison of three explicit criteria. Clin Ther 27(1):88–99. doi:10.1016/j.clinthera.2005.01.009
Zuckerman IH, Hernandez JJ, Gruber-Baldini AL, Hebel JR, Stuart B, Zimmerman S, Magaziner J (2005) Potentially inappropriate prescribing before and after nursing home admission among patients with and without dementia. Am J Geriatr Pharmacother 3(4):246–254
Lay HY, Hwang SJ, Chen TJ, Lin MH, Chen LK (2009) Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program. Clin Ther 31:1859–1870
Akazawa M, Imai H, Igarashi A, Tsutani K (2010) Potentially inappropriate medication use in elderly Japanese patients. Am J Geriatr Pharmacother 8:146–160
Johnell K, Fastbom J, Rosen M, Leimanis A (2007) Inappropriate drug use in the elderly: a nationwide register-based study. Ann Pharmacother 41(7):1243–1248. doi:10.1345/aph.1K154
Leikola S, Dimitrow M, Lyles A, Pitkala K, Airaksinen M (2011) Potentially inappropriate medication use among Finnish non-institutionalized people aged ≥75 years: a register-based, cross-sectional, national study. Drug Aging 28:227–236. doi:10.2165/11586890
Roquefeuil LD (2009) L'échantillon généraliste des bénéficiares: représentativité, portée et limites. Prat Organ Soins 40(3):213–223
Martin-Latry K, Begaud B (2010) Pharmacoepidemiological research using French reimbursement databases: yes we can! Pharmacoepidemiol Drug Saf 19(3):256–265. doi:10.1002/pds.1912
Latry P, Molimard M, Begaud B, Martin-Latry K (2010) How reimbursement databases can be used to support drug utilisation studies: example using the main French national health insurance system database. Eur J Clin Pharmacol 66(7):743–748. doi:10.1007/s00228-010-0819-0
Lechevallier-Michel N, Gautier-Bertrand M, Alperovitch A, Berr C, Belmin J, Legrain S, Saint-Jean O, Tavernier B, Dartigues JF, Fourrier-Reglat A (2005) Frequency and risk factors of potentially inappropriate medication use in a community-dwelling elderly population: results from the 3C Study. Eur J Clin Pharmacol 60(11):813–819. doi:10.1007/s00228-004-0851-z
Bouvenot G (2003) Etude de la prescription et de la consommation des vasodilatateurs en ambulatoire. Afssaps, Saint Denis
Chevreul K (2009) HTA in coverage and reimbursement decisions in France: toward a new paradigm? Euro Observer 11:5–6
Ness J, Hoth A, Barnett MJ, Shorr RI, Kaboli PJ (2006) Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events. Am J Geriatr Pharmacother 4(1):42–51. doi:10.1016/j.amjopharm.2006.03.008
Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE (2008) The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med 168:508–513
Fortin MP, Rouch I, Dauphinot V, Gédéon C, Genthon S, Bonnefoy M, Krolak-Salmon P (2011) Effects of anticholinergic drugs on verbal episodic memory function in the elderly. A retrospective, cross-sectional study. Drugs Aging 28(3):195–204
Ohayon MM, Lader MH (2002) Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry 63(9):817–825
Pelissolo A, Boyer P, Lepine JP, Bisserbe JC (1996) Epidemiology of the use of anxiolytic and hypnotic drugs in France and in the world. Encephale 22(3):187–196
Lechevallier N, Fourrier A, Berr C (2003) Benzodiazepine use in the elderly: the EVA Study. Rev Epidemiol Sante Publique 51(3):317–326
Lechevallier-Michel N, Berr C, Fourrier-Reglat A (2005) Incidence and characteristics of benzodiazepine use in an elderly cohort: the EVA study. Therapie 60(6):561–566
Pimlott NJ, Hux JE, Wilson LM, Kahan M, Li C, Rosser WW (2003) Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial. CMAJ 168(7):835–839
Kumar A, Fonarow GC, Eagle KA, Jirsch AT, Califf RM, Alberts MJ, Boden WE, Steg PG, Shao M, Bhatt DL, Cannon CP, Investigators REACH (2009) Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry. Crit Pathw Cardiol 8(3):104–111
Kern WV, de With K, Nink K, Steib-Bauert M, Schröder H (2006) Regional variation in outpatient antibiotic prescribing in Germany. Infection 34(5):269–273
Usher C, Bennett K, Feely J (2005) Regional variation in the prescribing for diabetes and use of secondary preventative therapies in Ireland. Pharmacoepidemiol Drug Saf 14(8):537–544
Lopez J, Meier J, Cunningham F, Siegel D (2004) Antihypertensive medications use in the Department of Veterans Affairs: a national analysis of prescribing patterns from 2000–2002. Am J Hypertens 17:1095–1099
Lecadet J (2003) Médicaments psychotropes: consommation et pratiques de prescription en France métropolitaine. II Données de comparaison régionales, 2000. Med Ass Maladie 34(4):233–248
Bocquier A, Bezzou K, Nauleau S, Verger P (2008) Dispensing of anxiolytics and hypnotics in southeastern France: demographic factors and determinants of geographic variations. Fundam Clin Pharmacol 22(3):323–333. doi:10.1111/j.1472-8206.2008.00587.x
Zhang Y, Baicker K, Newhouse JP (2010) Geographic variation in the quality of prescribing. N Engl J Med 363:1985–1988. doi:10.1056/NEJMp1010220
Zhang Y, Baicker K, Newhouse JP (2010) Geographic variation in Medicare drug spending. N Engl J Med 363:405–409
Song Y, Skinner J, Bynum J, Sutherland J, Wennberg JE, Fisher ES (2010) Regional variations in diagnostic practices. N Engl J Med 363:45–53
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bongue, B., Laroche, M.L., Gutton, S. et al. Potentially inappropriate drug prescription in the elderly in France: a population-based study from the French National Insurance Healthcare system. Eur J Clin Pharmacol 67, 1291–1299 (2011). https://doi.org/10.1007/s00228-011-1077-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-011-1077-5